These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 25557753)

  • 1. The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era.
    Jahn JL; Giovannucci EL; Stampfer MJ
    Int J Cancer; 2015 Dec; 137(12):2795-802. PubMed ID: 25557753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era.
    Konety BR; Bird VY; Deorah S; Dahmoush L
    J Urol; 2005 Nov; 174(5):1785-8; discussion 1788. PubMed ID: 16217287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National trends in the epidemiology of prostate cancer, 1973 to 1994: evidence for the effectiveness of prostate-specific antigen screening.
    Farkas A; Schneider D; Perrotti M; Cummings KB; Ward WS
    Urology; 1998 Sep; 52(3):444-8; discussion 448-9. PubMed ID: 9730458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden.
    Hugosson J; Aus G; Becker C; Carlsson S; Eriksson H; Lilja H; Lodding P; Tibblin G
    BJU Int; 2000 Jun; 85(9):1078-84. PubMed ID: 10848699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
    Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL
    BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Utilization of screening and treatment of prostate cancer in 2011].
    Tombal B
    Bull Mem Acad R Med Belg; 2011; 166(3-4):170-6; discussion 177. PubMed ID: 22375496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer association studies: pitfalls and solutions to cancer misclassification in the PSA era.
    Platz EA; De Marzo AM; Giovannucci E
    J Cell Biochem; 2004 Feb; 91(3):553-71. PubMed ID: 14755685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study.
    Stattin P; Vickers AJ; Sjoberg DD; Johansson R; Granfors T; Johansson M; Pettersson K; Scardino PT; Hallmans G; Lilja H
    Eur Urol; 2015 Aug; 68(2):207-13. PubMed ID: 25682340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of subclinical cancers by prostate-specific antigen screening in asymptomatic men from high-risk prostate cancer families.
    Matikainen MP; Schleutker J; Mörsky P; Kallioniemi OP; Tammela TL
    Clin Cancer Res; 1999 Jun; 5(6):1275-9. PubMed ID: 10389909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced risk of prostate cancer in U.S. Men with AIDS.
    Shiels MS; Goedert JJ; Moore RD; Platz EA; Engels EA
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2910-5. PubMed ID: 20837717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific antigen testing for prostate cancer: Depleting a limited pool of susceptible individuals?
    Valberg M; Grotmol T; Tretli S; Veierød MB; Moger TA; Devesa SS; Aalen OO
    Eur J Epidemiol; 2017 Jun; 32(6):511-520. PubMed ID: 27431530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day).
    Srinualnad S; Charoenkraikamol C; Toraksa S; Uiprasertkul M; Amornvesukit T; Taweemonkongsap T; Udompunturak S; Nualyong C; Tantiwong A
    J Med Assoc Thai; 2006 Jan; 89(1):37-42. PubMed ID: 16583579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.
    Etzioni R; Penson DF; Legler JM; di Tommaso D; Boer R; Gann PH; Feuer EJ
    J Natl Cancer Inst; 2002 Jul; 94(13):981-90. PubMed ID: 12096083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trade-Off between Treatment of Early Prostate Cancer and Incidence of Advanced Prostate Cancer in the Prostate Screening Era.
    Shen X; Kumar P
    J Urol; 2016 May; 195(5):1397-1402. PubMed ID: 26656266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostatic specific antigen for prostate cancer detection.
    Nogueira L; Corradi R; Eastham JA
    Int Braz J Urol; 2009; 35(5):521-9; discussion 530-2. PubMed ID: 19860930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019.
    Gandaglia G; Albers P; Abrahamsson PA; Briganti A; Catto JWF; Chapple CR; Montorsi F; Mottet N; Roobol MJ; Sønksen J; Wirth M; van Poppel H
    Eur Urol; 2019 Aug; 76(2):142-150. PubMed ID: 31092338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer.
    Candas B; Cusan L; Gomez JL; Diamond P; Suburu RE; Lévesque J; Brousseau G; Bélanger A; Labrie F
    Prostate; 2000 Sep; 45(1):19-35. PubMed ID: 10960839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal screening for prostate cancer with prostate-specific antigen.
    Smith DS; Catalona WJ; Herschman JD
    JAMA; 1996 Oct 23-30; 276(16):1309-15. PubMed ID: 8861989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Iran.
    Safarinejad MR
    Ann Oncol; 2006 Jul; 17(7):1166-71. PubMed ID: 16684791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current results on PSA-based prostate cancer detection].
    Graefen M; Schlomm T; Steuber T; Sauter G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Mar; 57(3):312-7. PubMed ID: 24562706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.